World Heart gets Canadian nod for refined LVAS (left ventricular assist system):
This article was originally published in Clinica
Health Canada has given World Heart the all-clear to sell a refined version of its Novacor LVAS (left ventricular assist system). The enhancements to the device are designed primarily to improve a recipient's quality-of-life by having a quieter device and smaller, lighter, longer-lasting battery packs, says the Ottawa, Canada firm. The refinements are already commercially available in Europe and under review for approval in the US.